Trademarkia Logo

Canada

C$
Trademark Search in Canada
Lilly in Red Script

View On IC.GC.CA

Lilly in Red Script
REGISTERED

on 15 May 2019

Last Applicant/ Owned by

Eli Lilly and Company

Lilly Corporate CenterIndianapolis, IN 46285

US

Serial Number

1857181 filed on 12th Sept 2017

Registration Number

TMA1021655 registered on 15th May 2019

Registration expiry Date

15th May 2034

Correspondent Address

BORDEN LADNER GERVAIS LLP

World Exchange Plaza100 Queen Street, Suite 1300Ottawa

ONTARIO

CA

K1P1J9

Lilly in Red Script

Trademark usage description

pharmaceutical preparations namely pharmaceutical preparations for the treatment of alopecia, alzheimer's disease, atopic dermatitis, autoimmune disea Read More

Vienna Information

29 . 1 . 1

Red, pink, orangeRouge, rose, orangé

Classification Information

Class [005]
Pharmaceutical preparations namely pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders namely osteoporosis, osteoarthritis, fracture healing, bone frailty due to extended ventilator use, hip replacement surgery and knee replacement surgery, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, arthritis, bursitis, tendonitis, osteonecrosis and Paget's disease, cancer, cardiovascular diseases, central nervous system diseases and disorders namely, anxiety disorders, depression, bipolar depression, bipolar disorder, treatment resistant depression, schizophrenia and cognitive impairment associated with schizophrenia, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders namely psoriasis, skin cancer and eczema, diabetes, dyslipidemia, endocrine diseases and disorders, namely Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus, gastrointestinal diseases and disorders, headaches, heart failure, hypoglycemia, inflammation and inflammatory diseases and disorders namely inflammatory bowel diseases, inflammatory connective tissue diseases and rheumatoid arthritis, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders namely metabolic syndrome, migraines, multiple sclerosis, muscle diseases and disorders namely myopathies, chronic fatigue syndrome, fibromyalgia and muscular dystrophy, neurodegenerative diseases and disorders namely Huntington's disease, Alzheimer's disease, and dementia, neurological disorders namely Alzheimer's disease, mild cognitive impairment, Parkinson's disease and multiple sclerosis, obesity, pain relief, Parkinson's disease, psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, ulcerative colitis; Diagnostic reagents for medical diagnostic use; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases and of oncology and of pain.

Classification kind code

11

Class [010]
Medical devices and apparatus, namely, hypodermic injectors and pumps for use with injection syringes and needles.

Classification kind code

11

Mark Details

Serial Number

1857181

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 50
on 8th Mar 2019		Allowed
Submitted for opposition 51
on 8th Mar 2019		Allowance Notice Sent
Submitted for opposition 42
on 21st Nov 2018		Advertised
Submitted for opposition 26
on 1st Nov 2018		Approved
Submitted for opposition 27
on 13th Sept 2018		Approval Notice Sent
Submitted for opposition 22
on 30th Apr 2018		Search Recorded
Submitted for opposition 20
on 30th Apr 2018		Examiner's First Report
Submitted for opposition 31
on 18th Sept 2017		Formalized
Submitted for opposition 1
on 13th Sept 2017		Created
Submitted for opposition 30
on 12th Sept 2017		Filed